KZR Insider Transactions
Transaction Date (SEC Report ) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
---|---|---|---|---|---|---|---|---|
2023-02-06 | Morningside Venture Investments Ltd | 10 percent owner | 5,447,993 | S-Sale | D | 40,000 | 6.88 | 275,320.00 |
2023-02-03 | Morningside Venture Investments Ltd | 10 percent owner | 5,487,993 | S-Sale | D | 25,000 | 7.15 | 178,650.00 |
2023-02-02 | Morningside Venture Investments Ltd | 10 percent owner | 5,512,993 | S-Sale | D | 50,000 | 7.19 | 359,500.00 |
2023-02-01 | Morningside Venture Investments Ltd | 10 percent owner | 5,562,993 | S-Sale | D | 40,000 | 6.95 | 278,000.00 |
2023-01-31 | Morningside Venture Investments Ltd | 10 percent owner | 5,602,993 | S-Sale | D | 30,000 | 7.08 | 212,400.00 |
2023-01-30 | Morningside Venture Investments Ltd | 10 percent owner | 5,632,993 | S-Sale | D | 30,000 | 6.91 | 207,300.00 |
2023-01-25 | Morningside Venture Investments Ltd | 10 percent owner | 5,662,993 | S-Sale | D | 50,000 | 6.85 | 342,500.00 |
2023-01-24 | Morningside Venture Investments Ltd | 10 percent owner | 5,712,993 | S-Sale | D | 80,000 | 6.98 | 558,400.00 |
2023-01-23 | Morningside Venture Investments Ltd | 10 percent owner | 5,792,993 | S-Sale | D | 80,000 | 6.81 | 544,800.00 |
2023-01-17 | Morningside Venture Investments Ltd | 10 percent owner | 5,872,993 | S-Sale | D | 6,114 | 6.79 | 41,514.06 |
2023-01-13 | Morningside Venture Investments Ltd | 10 percent owner | 5,879,107 | S-Sale | D | 1,971 | 7.15 | 14,092.65 |
2023-01-12 | Morningside Venture Investments Ltd | 10 percent owner | 5,881,078 | S-Sale | D | 5,000 | 6.77 | 33,850.00 |
2023-01-08 | Mordwinkin Nicholas Michael | officer: Chief Business Officer | 185,000 | A-Award | A | 185,000 | 6.84 | 1,265,400.00 |
2023-01-08 | Henig Noreen | officer: Chief Medical Officer | 220,000 | A-Award | A | 220,000 | 6.84 | 1,504,800.00 |
2023-01-08 | Fowler John Franklin | director, officer: CEO | 580,000 | A-Award | A | 580,000 | 6.84 | 3,967,200.00 |
2023-01-08 | Belsky Marc | officer: Chief Financial Officer | 195,000 | A-Award | A | 195,000 | 6.84 | 1,333,800.00 |
2023-01-08 | Kirk Christopher J. | director, officer: President and CSO | 190,000 | A-Award | A | 190,000 | 6.84 | 1,299,600.00 |
2023-01-06 | Morningside Venture Investments Ltd | 10 percent owner | 5,886,078 | S-Sale | D | 3,000 | 6.89 | 20,670.00 |
2023-01-05 | Morningside Venture Investments Ltd | 10 percent owner | 5,889,078 | S-Sale | D | 12,162 | 6.97 | 84,769.14 |
2023-01-04 | Morningside Venture Investments Ltd | 10 percent owner | 5,901,240 | S-Sale | D | 30,000 | 7.17 | 215,100.00 |
2023-01-03 | Morningside Venture Investments Ltd | 10 percent owner | 5,931,240 | S-Sale | D | 500 | 7.10 | 3,550.00 |
2022-12-29 | Morningside Venture Investments Ltd | 10 percent owner | 5,931,740 | S-Sale | D | 25,000 | 7.10 | 177,500.00 |
2022-11-10 | Fowler John Franklin | director, officer: CEO | 55,721 | M-Exempt | D | 27,000 | 0.90 | 24,300.00 |
2022-11-10 | Fowler John Franklin | director, officer: CEO | 393,904 | M-Exempt | A | 27,000 | 0.90 | 24,300.00 |
2022-10-18 | Morningside Venture Investments Ltd | 10 percent owner | 5,931,740 | G-Gift | D | 120,000 | 0.00 | 0.00 |
2022-10-04 | Morningside Venture Investments Ltd | 10 percent owner | 6,076,740 | S-Sale | D | 3,612 | 8.82 | 31,857.48 |
2022-10-03 | Morningside Venture Investments Ltd | 10 percent owner | 6,080,352 | S-Sale | D | 28,700 | 8.78 | 251,957.30 |
2022-08-01 | Mordwinkin Nicholas Michael | officer: Chief Business Officer | 200,000 | A-Award | A | 200,000 | 9.35 | 1,870,000.00 |
2022-06-23 | Kirk Christopher J. | director, officer: President and CSO | 123,361 | M-Exempt | D | 33,060 | 0.90 | 29,754.00 |
2022-06-23 | Kirk Christopher J. | director, officer: President and CSO | 381,484 | M-Exempt | A | 33,060 | 0.90 | 29,754.00 |
2022-06-16 | Kauffman Michael | director | 26,000 | A-Award | A | 26,000 | 4.80 | 124,800.00 |
2022-06-16 | Wallace Courtney | director | 26,000 | A-Award | A | 26,000 | 4.80 | 124,800.00 |
2022-06-16 | Klearman Micki | director | 26,000 | A-Award | A | 26,000 | 4.80 | 124,800.00 |
2022-06-16 | Garner Elizabeth | director | 26,000 | A-Award | A | 26,000 | 4.80 | 124,800.00 |
2022-06-16 | BERGER FRANKLIN M | director | 26,000 | A-Award | A | 26,000 | 4.80 | 124,800.00 |
2022-06-16 | COOPER GRAHAM K | director | 26,000 | A-Award | A | 26,000 | 4.80 | 124,800.00 |
2022-05-12 | COOPER GRAHAM K | director | 26,000 | A-Award | A | 26,000 | 5.52 | 143,520.00 |
2022-03-21 | BERGER FRANKLIN M | director | 890,691 | P-Purchase | A | 20,000 | 14.77 | 295,400.00 |
2022-03-18 | BERGER FRANKLIN M | director | 870,691 | P-Purchase | A | 45,000 | 17.00 | 765,000.00 |
2022-03-18 | BERGER FRANKLIN M | director | 825,691 | P-Purchase | A | 15,000 | 15.96 | 239,400.00 |
2022-01-05 | Henig Noreen | officer: Chief Medical Officer | 180,000 | A-Award | A | 180,000 | 14.55 | 2,619,000.00 |
2022-01-05 | Fowler John Franklin | director, officer: CEO | 500,000 | A-Award | A | 500,000 | 14.55 | 7,275,000.00 |
2022-01-05 | Kirk Christopher J. | director, officer: President and CSO | 170,000 | A-Award | A | 170,000 | 14.55 | 2,473,500.00 |
2022-01-05 | Belsky Marc | officer: CFO | 140,000 | A-Award | A | 140,000 | 14.55 | 2,037,000.00 |
2022-01-03 | Kauffman Michael | director | 3,896 | M-Exempt | D | 5,000 | 5.91 | 29,550.00 |
2022-01-03 | Kauffman Michael | director | 63,690 | S-Sale | D | 5,000 | 16.45 | 82,250.00 |
2022-01-03 | Kauffman Michael | director | 68,690 | M-Exempt | A | 5,000 | 5.91 | 29,550.00 |
2021-12-14 | Fowler John Franklin | director, officer: CEO | 82,721 | M-Exempt | D | 7,700 | 0.90 | 6,930.00 |
2021-12-14 | Fowler John Franklin | director, officer: CEO | 366,904 | M-Exempt | A | 7,700 | 0.90 | 6,930.00 |
2021-12-09 | Wallace Courtney | director | 52,000 | A-Award | A | 52,000 | 13.87 | 721,240.00 |
2021-09-22 | BERGER FRANKLIN M | director | 0 | M-Exempt | D | 8,896 | 5.60 | 49,817.60 |
2021-09-22 | BERGER FRANKLIN M | director | 810,691 | M-Exempt | A | 8,896 | 5.60 | 49,817.60 |
2021-09-21 | BERGER FRANKLIN M | director | 801,795 | M-Exempt | A | 8,896 | 7.63 | 67,876.48 |
2021-09-21 | BERGER FRANKLIN M | director | 792,899 | M-Exempt | A | 8,896 | 5.91 | 52,575.36 |
2021-06-28 | Sommadossi Jean-Pierre | director | 26,000 | A-Award | A | 26,000 | 5.59 | 145,340.00 |
2021-06-28 | Kauffman Michael | director | 26,000 | A-Award | A | 26,000 | 0.00 | 0.00 |
2021-06-28 | COOPER GRAHAM K | director | 26,000 | A-Award | A | 26,000 | 0.00 | 0.00 |
2021-06-28 | Dinges Jason | director | 26,000 | A-Award | A | 26,000 | 0.00 | 0.00 |
2021-06-28 | Klearman Micki | director | 26,000 | A-Award | A | 26,000 | 5.59 | 145,340.00 |
2021-06-28 | Garner Elizabeth | director | 26,000 | A-Award | A | 26,000 | 0.00 | 0.00 |
2021-06-28 | BERGER FRANKLIN M | director | 26,000 | A-Award | A | 26,000 | 5.59 | 145,340.00 |
2021-06-01 | Klearman Micki | director | 52,000 | A-Award | A | 52,000 | 5.94 | 308,880.00 |
2021-01-08 | Fowler John Franklin | director, officer: CEO | 1,200,000 | A-Award | A | 1,200,000 | 0.00 | 0.00 |
2021-01-08 | Belsky Marc | officer: CFO | 220,000 | A-Award | A | 220,000 | 0.00 | 0.00 |
2021-01-08 | Economides Vassiliki | officer: SVP, Strategy & External Aff. | 110,000 | A-Award | A | 110,000 | 0.00 | 0.00 |
2021-01-08 | Henig Noreen | officer: Chief Medical Officer | 280,000 | A-Award | A | 280,000 | 0.00 | 0.00 |
2021-01-08 | Kirk Christopher J. | director, officer: President and CSO | 260,000 | A-Award | A | 260,000 | 0.00 | 0.00 |
2020-12-31 | Fowler John Franklin | director, officer: CEO | 359,204 | M-Exempt | A | 16,000 | 0.90 | 14,400.00 |
2020-12-31 | Fowler John Franklin | director, officer: CEO | 90,421 | M-Exempt | D | 16,000 | 0.90 | 14,400.00 |
2020-06-24 | BERGER FRANKLIN M | director | 8,896 | A-Award | A | 8,896 | 0.00 | 0.00 |
2020-06-24 | Dinges Jason | director | 8,896 | A-Award | A | 8,896 | 0.00 | 0.00 |
2020-06-24 | Garner Elizabeth | director | 8,896 | A-Award | A | 8,896 | 0.00 | 0.00 |
2020-06-24 | Sommadossi Jean-Pierre | director | 8,896 | A-Award | A | 8,896 | 0.00 | 0.00 |
2020-06-24 | COOPER GRAHAM K | director | 8,896 | A-Award | A | 8,896 | 0.00 | 0.00 |
2020-06-24 | Kauffman Michael | director | 8,896 | A-Award | A | 8,896 | 0.00 | 0.00 |
2020-06-11 | BERGER FRANKLIN M | director | 784,003 | P-Purchase | A | 100,000 | 5.50 | 550,000.00 |
2020-06-11 | Equal Talent Investments Ltd | 10 percent owner | 6,254,545 | P-Purchase | A | 1,454,545 | 5.50 | 7,999,997.50 |
2020-05-01 | Henig Noreen | officer: Chief Medical Officer | 300,000 | A-Award | A | 300,000 | 0.00 | 0.00 |
2020-02-04 | Morningside Venture Investments Ltd | 10 percent owner | 6,109,052 | P-Purchase | A | 3,800,000 | 0.00 | 0.00 |
2020-02-04 | Kirk Christopher J. | director, officer: President and CSO | 342,609 | P-Purchase | A | 38,461 | 0.00 | 0.00 |
2020-02-04 | BERGER FRANKLIN M | director | 684,003 | P-Purchase | A | 120,846 | 0.00 | 0.00 |
2020-02-04 | Economides Vassiliki | officer: SVP, Strategy & External Aff. | 7,570 | P-Purchase | A | 5,769 | 0.00 | 0.00 |
2020-02-04 | Belsky Marc | officer: CFO | 15,384 | P-Purchase | A | 15,384 | 0.00 | 0.00 |
2020-02-04 | Fowler John Franklin | director, officer: CEO | 38,461 | P-Purchase | A | 38,461 | 0.00 | 0.00 |
2020-01-12 | Economides Vassiliki | officer: SVP, Strategy & External Aff. | 62,500 | A-Award | A | 62,500 | 0.00 | 0.00 |
2020-01-12 | Kirk Christopher J. | director, officer: President and CSO | 125,000 | A-Award | A | 125,000 | 0.00 | 0.00 |
2020-01-12 | Fowler John Franklin | director, officer: CEO | 200,000 | A-Award | A | 200,000 | 0.00 | 0.00 |
2020-01-12 | Belsky Marc | officer: CFO | 90,000 | A-Award | A | 90,000 | 0.00 | 0.00 |
2019-12-19 | Fowler John Franklin | director, officer: CEO | 346,954 | M-Exempt | A | 50,000 | 0.00 | 0.00 |
2019-12-19 | Fowler John Franklin | director, officer: CEO | 106,421 | M-Exempt | D | 50,000 | 0.00 | 0.00 |
2019-12-18 | Garner Elizabeth | director | 17,793 | A-Award | A | 17,793 | 0.00 | 0.00 |
2019-11-13 | Belsky Marc | officer: CFO | 2,000 | P-Purchase | A | 800 | 0.00 | 0.00 |
2019-10-10 | Fowler John Franklin | director, officer: CEO | 296,954 | P-Purchase | A | 1,000 | 0.00 | 0.00 |
2019-09-06 | Economides Vassiliki | officer: SVP, Strategy & External Aff. | 35,000 | A-Award | A | 35,000 | 3.38 | 118,300.00 |
2019-09-06 | Belsky Marc | officer: CFO | 60,000 | A-Award | A | 60,000 | 0.00 | 0.00 |
2019-08-20 | Belsky Marc | officer: CFO | 1,200 | P-Purchase | A | 200 | 4.42 | 884.00 |
2019-08-20 | Economides Vassiliki | officer: SVP, Strategy & External Aff. | 1,801 | P-Purchase | A | 350 | 0.00 | 0.00 |
2019-08-13 | Kirk Christopher J. | director, officer: President and CSO | 302,934 | P-Purchase | A | 5,000 | 0.00 | 0.00 |
2019-08-13 | Fowler John Franklin | director, officer: CEO | 295,954 | P-Purchase | A | 2,000 | 0.00 | 0.00 |
2019-08-09 | Fowler John Franklin | director, officer: CEO | 293,204 | P-Purchase | A | 500 | 0.00 | 0.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Group doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Group or anyone involved with Discounting Cash Flows Group will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.